Pharsight

Drugs that contain Fluticasone Propionate

1. Armonair Digihaler patents expiration

ARMONAIR DIGIHALER's oppositions filed in EPO
ARMONAIR DIGIHALER IPR and PTAB Proceedings
Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8006690 TEVA PHARM Reservoir pressure system for medicament inhaler
Jun, 2021

(2 years ago)

US6718972 TEVA PHARM Dose metering system for medicament inhaler
Jun, 2021

(2 years ago)

US6748947 TEVA PHARM De-agglomerator for breath-actuated dry powder inhaler
Jun, 2021

(2 years ago)

US6701917 TEVA PHARM Dose counter for medicament inhaler
Jun, 2021

(2 years ago)

US6871646 TEVA PHARM De-agglomerator for breath-actuated dry powder inhaler
Jun, 2021

(2 years ago)

US7540282 TEVA PHARM Reservoir pressure system for medicament inhaler
May, 2023

(1 year, 19 days ago)

US7540282

(Pediatric)

TEVA PHARM Reservoir pressure system for medicament inhaler
Nov, 2023

(6 months ago)

US9616024 TEVA PHARM Process for preparing a medicament
Sep, 2024

(3 months from now)

US9616024

(Pediatric)

TEVA PHARM Process for preparing a medicament
Mar, 2025

(9 months from now)

US9463288 TEVA PHARM Dry powder inhalation apparatus
May, 2025

(11 months from now)

US10765820 TEVA PHARM Dry powder inhalation apparatus
May, 2025

(11 months from now)

US10765820

(Pediatric)

TEVA PHARM Dry powder inhalation apparatus
Nov, 2025

(1 year, 5 months from now)

US9463288

(Pediatric)

TEVA PHARM Dry powder inhalation apparatus
Nov, 2025

(1 year, 5 months from now)

US8651103 TEVA PHARM Dry powder inhalation apparatus
Mar, 2028

(3 years from now)

US8651103

(Pediatric)

TEVA PHARM Dry powder inhalation apparatus
Sep, 2028

(4 years from now)

US10195375 TEVA PHARM Airflow adaptor for a breath-actuated dry powder inhaler
Feb, 2031

(6 years from now)

US9731087 TEVA PHARM Dose counter for inhaler having a bore and shaft arrangement
May, 2031

(6 years from now)

US10124131 TEVA PHARM Dose counter for inhaler having an anti-reverse rotation actuator
May, 2031

(6 years from now)

US10022510 TEVA PHARM Dose counters for inhalers, inhalers and methods of assembly thereof
May, 2031

(6 years from now)

US9216260 TEVA PHARM Dose counters for inhalers, inhalers and methods of assembly thereof
Jun, 2031

(7 years from now)

US10195375

(Pediatric)

TEVA PHARM Airflow adaptor for a breath-actuated dry powder inhaler
Aug, 2031

(7 years from now)

US10124131

(Pediatric)

TEVA PHARM Dose counter for inhaler having an anti-reverse rotation actuator
Nov, 2031

(7 years from now)

US10022510

(Pediatric)

TEVA PHARM Dose counters for inhalers, inhalers and methods of assembly thereof
Nov, 2031

(7 years from now)

US9731087

(Pediatric)

TEVA PHARM Dose counter for inhaler having a bore and shaft arrangement
Nov, 2031

(7 years from now)

US9216260

(Pediatric)

TEVA PHARM Dose counters for inhalers, inhalers and methods of assembly thereof
Dec, 2031

(7 years from now)

US10561808 TEVA PHARM Dose counter for inhaler having an anti-reverse rotation actuator
Jan, 2032

(7 years from now)

US8978966 TEVA PHARM Dose counters for inhalers, inhalers and methods of assembly thereof
Jan, 2032

(7 years from now)

US8714149 TEVA PHARM Airflow adaptor for a breath-actuated dry powder inhaler
Feb, 2032

(7 years from now)

US10561808

(Pediatric)

TEVA PHARM Dose counter for inhaler having an anti-reverse rotation actuator
Jul, 2032

(8 years from now)

US8978966

(Pediatric)

TEVA PHARM Dose counters for inhalers, inhalers and methods of assembly thereof
Jul, 2032

(8 years from now)

US8714149

(Pediatric)

TEVA PHARM Airflow adaptor for a breath-actuated dry powder inhaler
Aug, 2032

(8 years from now)

US9782551 TEVA PHARM Compliance monitoring module for a breath-actuated inhaler
Aug, 2035

(11 years from now)

US9782550 TEVA PHARM Compliance monitoring module for a breath-actuated inhaler
Aug, 2035

(11 years from now)

US10918816 TEVA PHARM Compliance monitoring module for a breath-actuated inhaler
Dec, 2035

(11 years from now)

US9782550

(Pediatric)

TEVA PHARM Compliance monitoring module for a breath-actuated inhaler
Feb, 2036

(11 years from now)

US9782551

(Pediatric)

TEVA PHARM Compliance monitoring module for a breath-actuated inhaler
Feb, 2036

(11 years from now)

US10918816

(Pediatric)

TEVA PHARM Compliance monitoring module for a breath-actuated inhaler
Jun, 2036

(12 years from now)

US10569034 TEVA PHARM Compliance monitoring module for a breath-actuated inhaler
Aug, 2036

(12 years from now)

US10569034

(Pediatric)

TEVA PHARM Compliance monitoring module for a breath-actuated inhaler
Feb, 2037

(12 years from now)

US11351317 TEVA PHARM Drug delivery device with electronics
Feb, 2038

(13 years from now)

US11351317

(Pediatric)

TEVA PHARM Drug delivery device with electronics
Aug, 2038

(14 years from now)

US11357935 TEVA PHARM Drug delivery device with electronics
Sep, 2038

(14 years from now)

US11000653 TEVA PHARM Inhaler
Dec, 2038

(14 years from now)

US11357935

(Pediatric)

TEVA PHARM Drug delivery device with electronics
Mar, 2039

(14 years from now)

US11000653

(Pediatric)

TEVA PHARM Inhaler
Jun, 2039

(15 years from now)

US11344685 TEVA PHARM Drug delivery device with electronics
Sep, 2039

(15 years from now)

US11344685

(Pediatric)

TEVA PHARM Drug delivery device with electronics
Mar, 2040

(15 years from now)

US11439777 TEVA PHARM Drug delivery device with electronics
May, 2040

(16 years from now)

US11464923 TEVA PHARM Inhaler system
Jun, 2040

(16 years from now)

US11173259 TEVA PHARM Drug delivery device with electronics and power management
Jul, 2040

(16 years from now)

US11439777

(Pediatric)

TEVA PHARM Drug delivery device with electronics
Nov, 2040

(16 years from now)

US11464923

(Pediatric)

TEVA PHARM Inhaler system
Dec, 2040

(16 years from now)

US11173259

(Pediatric)

TEVA PHARM Drug delivery device with electronics and power management
Jan, 2041

(16 years from now)

US11266796 TEVA PHARM Inhalation device with integrated electronics
Feb, 2041

(16 years from now)

US11266796

(Pediatric)

TEVA PHARM Inhalation device with integrated electronics
Aug, 2041

(17 years from now)

Drug Exclusivity Drug Exclusivity Expiration
New Patient Population(NPP) Jul 09, 2024
New Strength(NS) Jul 09, 2024
Pediatric Exclusivity(PED) Jan 09, 2025
New Product(NP) Jan 27, 2020

Market Authorisation Date: 08 April, 2022

Treatment: NA

Dosage: POWDER;INHALATION

More Information on Dosage

ARMONAIR DIGIHALER family patents

Family Patents

2. Armonair Respiclick patents expiration

ARMONAIR RESPICLICK's oppositions filed in EPO
ARMONAIR RESPICLICK IPR and PTAB Proceedings
Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US6446627 TEVA PHARM Inhaler dose counter
Dec, 2017

(6 years ago)

US8006690 TEVA PHARM Reservoir pressure system for medicament inhaler
Jun, 2021

(2 years ago)

US6718972 TEVA PHARM Dose metering system for medicament inhaler
Jun, 2021

(2 years ago)

US6748947 TEVA PHARM De-agglomerator for breath-actuated dry powder inhaler
Jun, 2021

(2 years ago)

US6871646 TEVA PHARM De-agglomerator for breath-actuated dry powder inhaler
Jun, 2021

(2 years ago)

US6701917 TEVA PHARM Dose counter for medicament inhaler
Jun, 2021

(2 years ago)

US7540282 TEVA PHARM Reservoir pressure system for medicament inhaler
May, 2023

(1 year, 19 days ago)

US7540282

(Pediatric)

TEVA PHARM Reservoir pressure system for medicament inhaler
Nov, 2023

(6 months ago)

US9616024 TEVA PHARM Process for preparing a medicament
Sep, 2024

(3 months from now)

US9616024

(Pediatric)

TEVA PHARM Process for preparing a medicament
Mar, 2025

(9 months from now)

US9463288 TEVA PHARM Dry powder inhalation apparatus
May, 2025

(11 months from now)

US10765820 TEVA PHARM Dry powder inhalation apparatus
May, 2025

(11 months from now)

US10765820

(Pediatric)

TEVA PHARM Dry powder inhalation apparatus
Nov, 2025

(1 year, 5 months from now)

US9463288

(Pediatric)

TEVA PHARM Dry powder inhalation apparatus
Nov, 2025

(1 year, 5 months from now)

US8651103 TEVA PHARM Dry powder inhalation apparatus
Mar, 2028

(3 years from now)

US8651103

(Pediatric)

TEVA PHARM Dry powder inhalation apparatus
Sep, 2028

(4 years from now)

US10195375 TEVA PHARM Airflow adaptor for a breath-actuated dry powder inhaler
Feb, 2031

(6 years from now)

US10022510 TEVA PHARM Dose counters for inhalers, inhalers and methods of assembly thereof
May, 2031

(6 years from now)

US10124131 TEVA PHARM Dose counter for inhaler having an anti-reverse rotation actuator
May, 2031

(6 years from now)

US9731087 TEVA PHARM Dose counter for inhaler having a bore and shaft arrangement
May, 2031

(6 years from now)

US9216260 TEVA PHARM Dose counters for inhalers, inhalers and methods of assembly thereof
Jun, 2031

(7 years from now)

US10195375

(Pediatric)

TEVA PHARM Airflow adaptor for a breath-actuated dry powder inhaler
Aug, 2031

(7 years from now)

US9731087

(Pediatric)

TEVA PHARM Dose counter for inhaler having a bore and shaft arrangement
Nov, 2031

(7 years from now)

US10124131

(Pediatric)

TEVA PHARM Dose counter for inhaler having an anti-reverse rotation actuator
Nov, 2031

(7 years from now)

US10022510

(Pediatric)

TEVA PHARM Dose counters for inhalers, inhalers and methods of assembly thereof
Nov, 2031

(7 years from now)

US9216260

(Pediatric)

TEVA PHARM Dose counters for inhalers, inhalers and methods of assembly thereof
Dec, 2031

(7 years from now)

US10561808 TEVA PHARM Dose counter for inhaler having an anti-reverse rotation actuator
Jan, 2032

(7 years from now)

US8978966 TEVA PHARM Dose counters for inhalers, inhalers and methods of assembly thereof
Jan, 2032

(7 years from now)

US8714149 TEVA PHARM Airflow adaptor for a breath-actuated dry powder inhaler
Feb, 2032

(7 years from now)

US10561808

(Pediatric)

TEVA PHARM Dose counter for inhaler having an anti-reverse rotation actuator
Jul, 2032

(8 years from now)

US8978966

(Pediatric)

TEVA PHARM Dose counters for inhalers, inhalers and methods of assembly thereof
Jul, 2032

(8 years from now)

US8714149

(Pediatric)

TEVA PHARM Airflow adaptor for a breath-actuated dry powder inhaler
Aug, 2032

(8 years from now)

US10918816 TEVA PHARM Compliance monitoring module for a breath-actuated inhaler
Dec, 2035

(11 years from now)

Drug Exclusivity Drug Exclusivity Expiration
New Patient Population(NPP) Jul 09, 2024
New Strength(NS) Jul 09, 2024
Pediatric Exclusivity(PED) Jan 09, 2025
New Product(NP) Jan 27, 2020

Market Authorisation Date: 08 April, 2022

Treatment: NA

Dosage: POWDER;INHALATION

More Information on Dosage

ARMONAIR RESPICLICK family patents

Family Patents

Stay ahead of others in designing the generic launch strategy of these 5 blockbuster drugs expiring in next 5 years.

Get the exclusive patent insights now. Don't be the last to know.

3. Cutivate patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7300669 FOUGERA PHARMS Fluticasone lotion having improved vasoconstrictor activity
Oct, 2019

(4 years ago)

Drug Exclusivity Drug Exclusivity Expiration
New Patient Population(NPP) Jan 16, 2018

Market Authorisation Date: 31 March, 2005

Treatment: Relief of the inflammatory and pruritic manifestations of atopic dermatitis in patients one year of age or older

Dosage: LOTION;TOPICAL

How can I launch a generic of CUTIVATE before it's drug patent expiration?
More Information on Dosage

CUTIVATE family patents

Family Patents

4. Flovent Diskus 100 patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US5873360 GLAXO GRP LTD Inhalation device
Feb, 2016

(8 years ago)

US5873360

(Pediatric)

GLAXO GRP LTD Inhalation device
Aug, 2016

(7 years ago)

Market Authorisation Date: 29 September, 2000

Treatment: NA

Dosage: POWDER;INHALATION

More Information on Dosage

FLOVENT DISKUS 100 family patents

Family Patents

5. Flovent Diskus 250 patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US5873360 GLAXO GRP LTD Inhalation device
Feb, 2016

(8 years ago)

US5873360

(Pediatric)

GLAXO GRP LTD Inhalation device
Aug, 2016

(7 years ago)

Market Authorisation Date: 29 September, 2000

Treatment: NA

Dosage: POWDER;INHALATION

More Information on Dosage

FLOVENT DISKUS 250 family patents

Family Patents

6. Flovent Diskus 50 patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US5873360 GLAXO GRP LTD Inhalation device
Feb, 2016

(8 years ago)

US5873360

(Pediatric)

GLAXO GRP LTD Inhalation device
Aug, 2016

(7 years ago)

Market Authorisation Date: 29 September, 2000

Treatment: NA

Dosage: POWDER;INHALATION

More Information on Dosage

FLOVENT DISKUS 50 family patents

Family Patents

7. Flovent Hfa patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US6251368 GLAXO GRP LTD Pharmaceutical aerosol formulation containing a particulate medicament, a propellant and substantially free of a surfactant
Dec, 2012

(11 years ago)

US6251368

(Pediatric)

GLAXO GRP LTD Pharmaceutical aerosol formulation containing a particulate medicament, a propellant and substantially free of a surfactant
Jun, 2013

(10 years ago)

US6596260 GLAXO GRP LTD Aerosol container and a method for storage and administration of a predetermined amount of a pharmaceutically active aerosol
Aug, 2014

(9 years ago)

US5658549 GLAXO GRP LTD Aerosol formulations containing propellant 134a and fluticasone propionate
Aug, 2014

(9 years ago)

US5674472 GLAXO GRP LTD Canisters containing aerosol formulations containing P134a and fluticasone propionate
Oct, 2014

(9 years ago)

US6596260

(Pediatric)

GLAXO GRP LTD Aerosol container and a method for storage and administration of a predetermined amount of a pharmaceutically active aerosol
Feb, 2015

(9 years ago)

US5658549

(Pediatric)

GLAXO GRP LTD Aerosol formulations containing propellant 134a and fluticasone propionate
Feb, 2015

(9 years ago)

US5674472

(Pediatric)

GLAXO GRP LTD Canisters containing aerosol formulations containing P134a and fluticasone propionate
Apr, 2015

(9 years ago)

US6170717 GLAXO GRP LTD Valve for aerosol container
Dec, 2017

(6 years ago)

US6315173 GLAXO GRP LTD Valve for aerosol container
Dec, 2017

(6 years ago)

US6510969 GLAXO GRP LTD Valve for aerosol container
Dec, 2017

(6 years ago)

US6966467 GLAXO GRP LTD Valve for aerosol container
Dec, 2017

(6 years ago)

US7143908 GLAXO GRP LTD Indicating device
Jan, 2018

(6 years ago)

US6435372 GLAXO GRP LTD Delivery system for a medicament and method for the assembly thereof
Jan, 2018

(6 years ago)

US6938796 GLAXO GRP LTD Indicating device
Jan, 2018

(6 years ago)

US6161724 GLAXO GRP LTD Indicating device
Jan, 2018

(6 years ago)

US6997349 GLAXO GRP LTD Indicating device
Jan, 2018

(6 years ago)

US6431168 GLAXO GRP LTD Dispenser with doses′ counter
Jun, 2018

(5 years ago)

US7107986 GLAXO GRP LTD Dispenser with doses' counter
Jun, 2018

(5 years ago)

US6315173

(Pediatric)

GLAXO GRP LTD Valve for aerosol container
Jun, 2018

(5 years ago)

US6510969

(Pediatric)

GLAXO GRP LTD Valve for aerosol container
Jun, 2018

(5 years ago)

US6170717

(Pediatric)

GLAXO GRP LTD Valve for aerosol container
Jun, 2018

(5 years ago)

US6966467

(Pediatric)

GLAXO GRP LTD Valve for aerosol container
Jun, 2018

(5 years ago)

US6161724

(Pediatric)

GLAXO GRP LTD Indicating device
Jul, 2018

(5 years ago)

US6435372

(Pediatric)

GLAXO GRP LTD Delivery system for a medicament and method for the assembly thereof
Jul, 2018

(5 years ago)

US6997349

(Pediatric)

GLAXO GRP LTD Indicating device
Jul, 2018

(5 years ago)

US7143908

(Pediatric)

GLAXO GRP LTD Indicating device
Jul, 2018

(5 years ago)

US6938796

(Pediatric)

GLAXO GRP LTD Indicating device
Jul, 2018

(5 years ago)

US7350676 GLAXO GRP LTD Valve for aerosol container
Aug, 2018

(5 years ago)

US6431168

(Pediatric)

GLAXO GRP LTD Dispenser with doses′ counter
Dec, 2018

(5 years ago)

US7350676

(Pediatric)

GLAXO GRP LTD Valve for aerosol container
Feb, 2019

(5 years ago)

US7107986

(Pediatric)

GLAXO GRP LTD Dispenser with doses' counter
Dec, 2019

(4 years ago)

US9861771 GLAXO GRP LTD Device housing for an aerosol container
Oct, 2020

(3 years ago)

US6743413 GLAXO GRP LTD Suspension aerosol formulations
Jun, 2021

(2 years ago)

US6743413

(Pediatric)

GLAXO GRP LTD Suspension aerosol formulations
Dec, 2021

(2 years ago)

US7832351 GLAXO GRP LTD Actuation indicator for a dispensing device
Jun, 2023

(11 months ago)

US7832351

(Pediatric)

GLAXO GRP LTD Actuation indicator for a dispensing device
Dec, 2023

(5 months ago)

US7500444 GLAXO GRP LTD Actuation indicator for a dispensing device
Feb, 2026

(1 year, 9 months from now)

US7500444

(Pediatric)

GLAXO GRP LTD Actuation indicator for a dispensing device
Aug, 2026

(2 years from now)

Market Authorisation Date: 14 May, 2004

Treatment: A method of treating respiratory disorders, e.g., asthma, which comprises administration by inhalation of an effective amount of a pharmaceutical formulation as claimed in us patent no. 5658549; Metho...

Dosage: AEROSOL, METERED;INHALATION

How can I launch a generic of FLOVENT HFA before it's drug patent expiration?
More Information on Dosage

FLOVENT HFA family patents

Family Patents

8. Xhance patents expiration

XHANCE's oppositions filed in EPO
Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8555878 OPTINOSE US INC Nasal delivery device
Mar, 2020

(4 years ago)

US9468727 OPTINOSE US INC Nasal delivery
Jul, 2020

(3 years ago)

US6715485 OPTINOSE US INC Nasal delivery device
Sep, 2020

(3 years ago)

US9072857 OPTINOSE US INC Nasal delivery device
Apr, 2021

(3 years ago)

US8327844 OPTINOSE US INC Nasal delivery method
Oct, 2023

(6 months ago)

US8522778 OPTINOSE US INC Nasal devices
Apr, 2024

(a month ago)

US7975690 OPTINOSE US INC Nasal devices
Dec, 2025

(1 year, 7 months from now)

US10124132 OPTINOSE US INC Nasal delivery
Mar, 2027

(2 years from now)

US11602603 OPTINOSE US INC Nasal delivery devices
Oct, 2028

(4 years from now)

US10076615 OPTINOSE US INC Nasal delivery
Jul, 2029

(5 years from now)

US8550073 OPTINOSE US INC Nasal delivery
Oct, 2029

(5 years from now)

US8978647 OPTINOSE US INC Nasal delivery
Dec, 2030

(6 years from now)

US10252010 OPTINOSE US INC Nasal delivery devices
Feb, 2031

(6 years from now)

US11033696 OPTINOSE US INC Nasal delivery devices
May, 2033

(8 years from now)

US10179216 OPTINOSE US INC Nasal delivery devices
Jul, 2033

(9 years from now)

US10478574 OPTINOSE US INC Nasal administration
Nov, 2033

(9 years from now)

US10076614 OPTINOSE US INC Nasal delivery devices
Oct, 2034

(10 years from now)

US10300229 OPTINOSE US INC Nasal delivery devices
Jul, 2035

(11 years from now)

US11554229 OPTINOSE US INC Nasal administration
Feb, 2036

(11 years from now)

Drug Exclusivity Drug Exclusivity Expiration
New Indication(I-940) Mar 15, 2027
New Product(NP) Sep 18, 2020

Market Authorisation Date: 18 September, 2017

Treatment: Method of delivering fluticasone propionate to a nasal airway

Dosage: SPRAY, METERED;NASAL

More Information on Dosage

XHANCE family patents

Family Patents